We are testing a new system for linking grants to scientists.
The funding information displayed below comes from the
NIH Research Portfolio Online Reporting Tools and the
NSF Award Database.
The grant data on this page is limited to grants awarded in the United States and is thus partial. It can nonetheless be used to understand how funding patterns influence mentorship networks and vice-versa, which has deep implications on how research is done.
You can help! If you notice any innacuracies, please
sign in and mark grants as correct or incorrect matches.
Sign in to see low-probability grants and correct any errors in linkage between grants and researchers.
High-probability grants
According to our matching algorithm, Luye Qin is the likely recipient of the following grants.
Years |
Recipients |
Code |
Title / Keywords |
Matching score |
2018 — 2019 |
Qin, Luye |
R03Activity Code Description: To provide research support specifically limited in time and amount for studies in categorical program areas. Small grants provide flexibility for initiating studies which are generally for preliminary short-term projects and are non-renewable. |
Chemicogenetic Rescue of Autism-Like Social Deficits in Shank3-Deficient Mice @ State University of New York At Buffalo
Project Summary/Abstract Chemicogenetic rescue of autism-like social deficits in Shank3-deficient mice A hallmark for autism spectrum disorders (ASD) is social deficits and restricted & repetitive behaviors. Presently, there is no known cure for ASD. The goal of this R03 proposal is to find a novel, mechanism-based intervention for potential treatment of ASD in a mouse model. ASD are often associated with abnormalities of the N-methyl- D-aspartate (NMDA) receptors function. Haploinsufficiency of the Shank3 gene due to deletion or de novo mutation has been linked to autism in human genetics studies. Our recent studies showed Shank3-deficient mice exhibit autism-like social deficits and restricted & repetitive behaviors, as well as the significantly diminished NMDA receptors synaptic function in prefrontal cortex (PFC), a brain region controlling high-level ?executive? functions, all of which are impaired in ASD. We hypothesize that using the chemicogenetic technology to elevate PFC pyramidal neuronal activity will rescue autism-like social and diminished NMDA receptors synaptic deficits in Shank3-deficient mice. To test this, combined electrophysiological, behavioral, molecular and biochemical approaches will be used to address two important questions: (1) Does chemicogenetic elevating the synaptic activity of PFC pyramidal neurons rescue autism-like behavioral and synaptic deficits in Shank3-deficient mice? (2) What are the molecular mechanisms underlying the rescuing effect of chemicogenetic activation of PFC pyramidal neurons on autistic deficits in Shank3-deficient mice? Results gained from this study will help to identify molecular and cellular targets for the design of novel therapeutic strategies for ASD.
|
1 |